Arbutus Biopharma Corporation (FRA:I9DN)

Arbutus Biopharma Revenue

Arbutus Biopharma had revenue of $529.00K USD in the quarter ending September 30, 2025, a decrease of -60.49%. This brings the company's revenue in the last twelve months to $14.61M, up 116.64% year-over-year. In the year 2024, Arbutus Biopharma had annual revenue of $6.17M, down -65.98%.

• Revenue (ttm): $14.61M
• Revenue Growth: +116.64%
• P/S Ratio: 58.76
• Revenue / Employee: $331.95K
• Employees: 44
• Market Cap: 731.44M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.17M	-11.97M	-65.98%
Dec 31, 2023	18.14M	-20.88M	-53.51%
Dec 31, 2022	39.02M	28.03M	255.11%
Dec 31, 2021	10.99M	4.07M	58.92%
Dec 31, 2020	6.91M	903.00K	15.02%
Dec 31, 2019	6.01M	66.00K	1.11%
Dec 31, 2018	5.95M	-4.76M	-44.44%
Dec 31, 2017	10.70M	9.21M	617.64%
Dec 31, 2016	1.49M	-21.79M	-93.59%
Dec 31, 2015	23.28M	8.32M	55.66%
Dec 31, 2014	14.95M	-512.00K	-3.31%
Dec 31, 2013	15.47M	1.36M	9.64%
Dec 31, 2012	14.11M	-2.71M	-16.10%
Dec 31, 2011	16.81M	-4.62M	-21.54%
Dec 31, 2010	21.43M	7.66M	55.67%
Dec 31, 2009	13.76M	4.15M	43.15%
Dec 31, 2008	9.62M	-	-